Singapore- and Silicon Valley-based biotech company Engine Biosciences received $2.5 million from Coronet Ventures, the venture unit of US-based healthcare player Cedars-Sinai Medical Centre, last week.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
